Forte Biosciences Inc. (FBRX)
7.75
-1.35 (-14.84%)
At close: Mar 03, 2025, 3:59 PM
7.68
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST
Forte Biosciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 11.96M | 41.1M | 42.04M | 58.77M | 6.94M | 40.81M | 35.93M | 5.51M | 8.15M |
| Short-Term Investments | 25.16M | n/a | n/a | n/a | 12.84M | 55.27M | 52.79M | 25.73M | 50.76M |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 544K | 486K | 786K | 1.24M | n/a | 1.36M | 227K | 2.15M | 1.52M |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.2M | 411K | 476K | 1.13M | 567K | 1.66M | 1.9M | 1.22M | 1.29M |
| Total Current Assets | 38.33M | 41.51M | 42.52M | 59.9M | 7.51M | 97.75M | 90.63M | 32.46M | 60.2M |
| Property-Plant & Equipment | 109K | n/a | n/a | 97K | 150.6K | 3.97M | 1.22M | 743K | 445K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 653K | 486K | 786K | 1.34M | 150.6K | 5.33M | 1.44M | 2.89M | 1.97M |
| Total Assets | 38.98M | 42M | 43.31M | 61.24M | 7.66M | 103.08M | 92.07M | 35.35M | 62.17M |
| Account Payables | 1.42M | 1.15M | 946K | 1.24M | 1.57M | 78.38K | 1.95M | 1.67M | 1.3M |
| Deferred Revenue | n/a | n/a | n/a | n/a | -4.74M | 36K | 59K | 79K | 145K |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 4.71M | 7.2M | 600K |
| Other Current Liabilities | 2.24M | 2.03M | 812K | 1.02M | 343.27K | 16.42M | 10.61M | 5.44M | 3.89M |
| Total Current Liabilities | 3.67M | 3.18M | 1.76M | 2.26M | 1.91M | 16.53M | 17.33M | 14.38M | 5.93M |
| Long-Term Debt | n/a | n/a | n/a | n/a | 4.03M | 26.2M | 3.63M | 13.78M | 16.87M |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 6.49M | 2.2M | n/a | 126K | 176K |
| Total Long-Term Liabilities | n/a | 1.15M | n/a | n/a | 10.51M | 28.4M | 3.66M | 13.97M | 17.16M |
| Total Liabilities | 3.67M | 3.18M | 1.76M | 2.26M | 12.43M | 44.94M | 20.99M | 28.36M | 23.09M |
| Total Debt | n/a | n/a | n/a | n/a | 8.77M | 26.2M | 10.82M | 20.98M | 17.47M |
| Common Stock | 36K | 21K | 15K | 13K | 1K | 23K | 20K | 2K | 2K |
| Retained Earnings | -118.52M | -87.04M | -73.17M | -51.46M | -4.97M | -215.88M | -166.93M | -128M | -94.51M |
| Comprehensive Income | 4K | n/a | -43.31M | -61.24M | 10K | -23K | -34K | -2.41M | -58K |
| Shareholders Equity | 35.31M | 38.82M | 41.55M | 58.98M | -4.77M | 58.15M | 71.08M | 7M | 39.08M |
| Total Investments | 25.16M | n/a | n/a | n/a | 12.84M | 55.27M | 52.79M | 25.73M | 50.76M |